Publication | Closed Access

Durability of insulin degludec plus liraglutide versus insulin glargine U100 as initial injectable therapy in type 2 diabetes (DUAL VIII): a multicentre, open-label, phase 3b, randomised controlled trial

Diabetes ManagementDual ViiiInsulin ManagementDiabetesType 2Diabetes MellitusInsulin DeliveryMedicinePhase 3B